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Allyl triphenylphosphonium bromide based mito-tracker capped silicon quantum dot (Mito-SiQDs) has been synthesized 
through an inverse micelle process. It was then fully characterized by transmission electron microscopy, energy-dispersive 
X-ray spectroscopy, dynamic light scattering techniques and X-ray photoelectron spectroscopic method. Energy dispersive
X-ray spectroscopy analyses of the quantum dots confirm the presence of carbon, silicon, phosphorous and bromine atoms
in Mito-SiQDs. Morphological study by transmission electron microscopy experiment showed the formation of the particles
of size 11-12 nm of quantum dot dimension. The high negative zeta potential value of –23.7 mV calculated from dynamic
light scattering study indicates the high stability of the circumvent agglomeration of Mito-SiQDs. The mito-tracker capped
silicon quantum dot has blue emission at 400 nm wavelength upon excitation at 327 nm. Mito-SiQDs has not shown any
significant cytotoxic effect with 10 to 50 μL/mL concentration on HeLa cell line for at least up to 12 h of its treatment. The
Mito-SiQDs would be useful a possible fluorescent marker to visualize mitochondrial subcellular compartment in living cell
through fluorescence imaging study.
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A considerable attention has been paid to silicon 
quantum dots (SiQDs) and nanoparticles (SiNPs) by 
the scientific community over the last 20 years due to 
their distinctive activities in various aspects of 
novel optical, mechanical, electronic and catalytic 
properties.
1,2
 Now, quantum dots (QDs) have acquired 
an incredible space of interest in the field of detection, 
biosensing, cellular imaging, drug delivery, therapeutic 
uses, optical marker in biomedical applications etc,
3-10
 
because of their remarkable photostability, good 
luminescence of narrow emission band and high 
fluorescent quantum yield. Again, silicon nanoparticles 
(SiNPs) are also significantly important as new 
fluorescent bioprobes considering their attractive 
advantages of controllable surface modification, 
inertness, abundant silicon source, high luminescence 
quantum yield, strong photostability, good bio-
compatibility having relatively low toxicity.
11-14
 So, the 
combination of these properties of SiQDs could 
generate a new horizon for bioimaging purposes as 
fluorescent cellular markers in a number of diagnostic 
tools and assays.
15,16
 Moreover, optical property of 
SiNPs remarkably changes when its particle size is 
reduced to less than the bulk Bohr exciton radius 
(4.6 nm for silicon).
17,18 
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 etc. are 
generally performed to synthesize SiQDs. Most 
of the synthetic methods follow either complicated 
procedures or drastic reaction conditions using 
hazardous reagents or using instrument with potential 
security. In this regard reverse micelles technique is 
good one,
34-37
 but still in this procedure a variety of 
reducing agents has been used.
38,39
 So, there is an 
increasing demand of acquiring a method of an 
easy-to-make SiQDs to explore the activity in 
biological system. 
Recently, subcellular-targeted therapy is a 
promising area in biomedical nanotechnology for 
cancer treatment due to their higher efficacy with 
minimum side effect. The therapeutic results could be 
improved by many folds if pharmaceutical agents are 




specifically and selectively directed toward the 
targeted organelle, i.e., pro-apoptotic compounds to 
mitochondria,
40,41
 otherwise the random interaction of 
pharmaceuticals with intracellular site of action leads 
to the unwanted results. The mitochondrion is a 
double-membrane of phospholipid bilayer enveloped 
cytoplasmic organelle to have its own internal 
genome. The mitochondria of eukaryotic cells are the 
indispensable source of energy for survival and the 
translocation of proapoptotic proteins from the 
mitochondrial inter membrane space to the cytosol is 
regulated for controlling the activation of programmed 
cell death (so-called apoptosis) mechanism.
42
 Thus, 
nowadays it’s a huge challenge to the researchers to 
design mitochondria targeted pharmaceuticals and 
drug carriers considering the mitochondrion as an 
important therapeutic target in cancer therapy.
43-45
  
In this context SiQD is a good choice to employ for 
biomedical applications as it fulfils the essential 
criteria of water-solubility as well as hydrophilicity to 
prevent aggregation and precipitation in a biological 
environment with a considerable photoluminescence 




Considering the above fact, herein we demonstrate 
a water-soluble allyl triphenylphosphonium bromide 
based mito-tracker capped silicon quantum dot (Mito-
SiQDs) as a mitochondrial-targetable moiety which is 
easy to synthesize exploring a simple two-step 
procedure of high yield and selectivity at room-
temperature. To the best of our knowledge so far, the 
step of functionalization to acquire the SiQDs is a 
new approach. The surface of QDs has been 
functionalized by triphenylphosphonium cation as 
water-soluble component and which can act as 
mitochondrial-targetable moiety. The synthesized 
isolated material has been characterized as Mito-
SiQDs with the help of transmission electron 
microscopy (TEM), fluorescence spectrophotometry 
and X-ray photoelectron spectroscopy (XPS) 
analyses. The strong blue fluorescence (em: 400 nm) 
of this material was recorded under excitation of  
327 nm in aqueous medium. Mito-SiQDs did not show 
any significant cytotoxic effect with 10 to 50 μL/mL 
concentration on this HeLa cell line for at least up to 
12 h of its treatment. 
 
Materials and Methods 
All chemicals and reagents and spectroscopic grade 
solvents were purchased from Sigma. HITACHI  
F-7000 fluorescence spectrophotometer was used  
for the fluorescence spectra in all experiments. The 
morphological analysis and selected area electron 
diffraction (SAED) study of the synthesized Mito-
SQDs was carried out by Jeol JEM 2100 HR  
with EELS transmission electron microscopy (TEM). 
XPS study was carried out by PHI 5000 Versa  
Prob II, FEI Inc. 
 
Cell cytotoxicity assay 
In order to study the cytotoxicity of Mito-SiQDs, 
3-(4,5-dimethylthiazol-2-yl)-2,S-diphenyltetrazolium 
bromide (MTT) assay was carried out following the 
procedure described earlier. After the treatment of 
Mito-SiQDs (10, 20, 50, 100 and 200 μL/mL) for 6 h 
and 12 h, 10 μL of MTT solution (10 mg/mL PBS)  
was added in each well (96-well culture plate) and 
further incubated at 37 °C for 3 h at dark condition.  
Then, 100 μL of isopropyl alcohol (acidic) was added 
into each well after the removal of all media from 
wells. The produced formazan crystals (blue-violet) 
intracellularly were solubilized with 0.04 N acidic 
isopropyl alcohol. After that, the absorbance of the 
solution was recorded at wavelength 595 nm using a 
microplate reader (Model: THERMO MULTI SCAN 
EX). Three independent experiments were performed 
to calculate the mean. The cell cytotoxicity was 
calculated as % cell cytotoxicity = 100% – % cell 
viability. 
 
Synthesis of Mito-SiQDs 
The target material (Mito-SiQDs) was prepared in 
two steps. In the first step, HSiQDs was synthesized 
following the previously reported synthetic method of 
silicon QDs by inverse micelle.
47-49
 In the second step, 
a mixture of 1.0 mL 0.1 M methanolic solution of 
hexachloro-platinum and triphenyl-allyl-phosphonium 
bromide (50.0 mg) in 5.0 mL methanol solution  
was added to the methanolic solution of HSiQDs  
(20.0 mL) obtained from the first step using SiCl4  
(90.0 L). The solution was stirred for 5 h in room 
temperature. Removal of solvents by a rotary 
evaporator led to the formation of white dry powder. 
The unreacted surfactant as impurity in the dry 
powder was removed through dispersion into 20 mL 
of Milli-Q water followed by sonication and then by 
consecutive filtration through a 0.22 µm Milipore. 
Express PES membrane and dialysis for 2 days in 
slide-A-Lyzer dialysis cassette G2, 2000 MWCO,  
15 mL capacity to obtain the aqueous solution of 
Mito-SiQDs in pure form. 




Results and Discussion 
 
Synthesis and characterisation of Mito-SQDs 
Synthesis of the material (Mito-SiQDs) involves 
two steps. In the first step HSiQDs from SiCl4 
following the literature method and in the second step 
conversion of HSiQDs to Mito-SiQDs was performed 
(Scheme 1). The second step is very important for  
the functionalization of the surface of HSQDs to 
produce Mito-SiQDs with the help of Chalk-Harrod 
hydrosilylation reaction with a modification
50
  
using K2PtCl6 as catalyst taking usual precaution for 
isolation. To the best of our knowledge so far, this 
step of functionalization is a new approach to obtain 
silicon quantum dots (SiQDs). 
 
Morphological analysis 
Size and morphology of the synthesized Mito-SiQDs 
were confirmed from the TEM micrograph and  
DLS experiment. Fig. 1a shows the formation of the 
Mito-SiQDs with a size of 11-12 nm which are of 
quantum dot dimension. The selected area of electron 
diffraction (SAED) pattern (Fig. 1b) confirms highly 
crystalline nature of the QDs. Five bright concentric 
rings seen in the image are due to reflections from (111), 
(200), (220), (311) and (222) planes typical of the FCC 
lattice nature of the material.
52
 Energy dispersive X-ray 
spectroscopy (EDS) analysis of the obtained mito-
tracker capped silicon quantum dot shows that this 
compound contained carbon, silicon, phosphorous  
and bromine atoms. 
 
 




Fig. 1 ⸺ (a) TEM image, (b) SAED pattern and (c) EDS analysis spectrum of Mito-SiQDs 




The size of particles obtained in the DLS may not 
coincide with the size obtained by TEM images as 
DLS measurement reveals the hydrodynamic radius 
of the particles along with the overall mobility of the 
entity. Hence, the size of Mito-SiQDs ~43 nm was 
measured by DLS measurement (Fig. 2), which is 
contrary to that observed by TEM (11-12 nm).  
Zeta potential value is an indication of the stability of 
the colloidal solution. The high negative potential of 
solution indicates high stability of this circumvent 
agglomeration. Experimentally, we have found  
that Mito-SiQDs has zeta potential of –23.7 mV  
(Fig. 3). This high negative potential indicates the 
formation of small nano-dimensional particles which 
are stabilized by allyl triphenylphosphonium bromide 
providing protection against precipitation. The low 
conductivity value of this material, 0.21 mS/cm 
represents the formation of nano-dimensional entities 
in this case because smaller particle size increases the 
overall charge density on the surface. This also 
enhances inter-particle repulsion as seen in the higher 
negative zeta potential value.  
 
XPS analysis 
XPS analysis of the prepared Mito-SiQDs showed 
that the binding energies of 284.96 eV, 284.95 eV, 
287.44 eV and 283.75 eV corresponding to the C 1s 
of C-C, C-H, C-P and C-Si bonds of allylated silicon 
quantum dot, respectively. Furthermore, the binding 
energy of Si 2p at 100.56 eV indicated the presence of 
Si-C bond and 99.71 eV for Si-Si bond in the core. 
Binding energy at 70.22 eV revealed the presence of 
Br-P bond at the matrix (Fig. 4). All these findings 
 
 
Fig. 2 ⸺ Dynamic light scattering spectrum displays the size  
and distribution of allyl triphenylphosphonium bromide-capped 








Fig. 4 ⸺ XPS core-level spectra of Mito-SiQDs. Dotted line is experimental data that is fitted with various mixed components. (a) C 1s, 
(b) Si 2p, (c) Br 3d and (d) total scan 




proved the presence of allylated triphenylphosphino 
bromide in Mito-SiQDs and also the characteristic 
binding energy attributable to Si-C bonds confirmed 
the conversion of SiH4 to allylated quantum dots.  
The individual binding energy peaks corresponding to 
Si-H 2p3/2 could not be differentiated in the XPS as 
the particles were coated with the allyl triphenyl 
phosphonium bromide. All data presented are from 
capped SiNPs, because “uncapped” SiNPs as such  
do not exist. Without any capping, bare silicon 
nanoparticles are very quickly oxidized under ambient 
conditions and are not biocompatible. However, the 
involvement of the quantum dot particle in stabilizing 
the material is clearly reflected by the presence of Br
-
 
ions. These observations are quite in good consistent 
with literature.
53-57
 Binding energies of various bonds 
of Mito-SiQDs calculated through XPS analysis were 
presented in Table 1. 
 
Design strategy and fluorescence Study 
Keeping in mind to target the mitochondria-
subcellular region, we have attached 
triphenylphosphonium bromide moiety which is well 
known for its mitochondrial-targetable behaviour. 
Here, the triphenylphosphonium bromide group behaves 
as a ‘targetable-engine’ which may force to enter into 
a particular sub-cellular compartment in living cells 
when Mito-SiQDs will be introduced as a fluorescent 
marker. Excitation-emission spectra are an important 
tool for the characterization of quantum dots. 
Excitation spectrum was recorded from 260 to 390 nm 
to study the optical properties of Mito-MSQDs  
(10 μL/mL) (Fig. 5a). It showed a prominent sharp 
peak at around 327 nm. The appearance of the peak at 
327 nm is the characteristic peak of Mito-SiQDs. 
Excitation spectra suggest the formation of highly 
stabilized Mito-SiQDs. For the emission study 
aqueous solution of this material was excited at  
327 nm and spectrum was recorded from 350 to  
650 nm at room temperature with emission maximum 
(λmax) at 400 nm as presented in Fig. 5b. Observed 
spectrum is an agreement with the literature data in 
favour of the formation of quantum dots and this 
emission of the QDs occurred probably due to the 
jump of promoted conduction band electron to the 
valence band.
36,49,51,58
 Thus, the fluorescent spectra 
revealed the successful formation of Mito-SiQDs. 
Theoretical literature report also suggests that 1-2 nm 
silicon quantum dots with a hydrogen or carbon surface 
termination have direct band gap for optical transitions 





The bio-compatibility as well as cytotoxic effect of 
Mito-SiQDs in the living cells, was tested against 
breast adenocarcinoma HeLa cells using a standard 
method, the MTT assay. This material exhibited about 
97, 95, 92, 88 and 82 % of cell viability at the 
concentration of 10, 20, 50, 100 and 200 μL/mL, 
respectively, when incubated for 6 h. Further, it 
showed about 95, 92, 90, 82 and 78 % of cell viability 
with the material concentration of 10, 20, 50, 100 and  
200 μL/mL, respectively when the incubation time 
increased to 12 h (Fig. 6). However, significant 
cytotoxicity was noticed for higher doses (200 μL/mL) 
of Mito-SiQDs irrespective of the incubation period. 
Therefore, the Mito-SiQDs at a concentration of  
10 to 50 μL/mL may be used safely for the purpose  
of fluorescence imaging of living cells. 
 
Table 1 ⸺ Binding energies of various bonds of Mito 
Peak position 
C 1s Bond C-C C-H C-P C-Si 
B.E. (eV) 284.96 284.95 287.44 283.78 
Si 2p Bond Si-C Si-Si   
B.E. (eV) 100.56 99.71   
Br 3d Bond Br-P    




Fig. 5 ⸺ (a) Excitation and (b) emission spectra of Mito-SiQDs (10 μL/mL) 






Fig. 6 ⸺ Cytotoxic data of Mito-SiQDs in breast adenocarcinoma 
HeLa cells incubated for 6 and 12 h 
 
Conclusions 
In summary, we have successfully prepared allyl 
triphenylphosphoniumbromide based quantum dots 
(Mito-SiQDs) through an inverse micelle process.  
It has been well characterized through various 
spectroscopic and morphological analyses. The strong 
blue fluorescence (em: 400 nm) of Mito-SiQDs was 
recorded under excitation of 327 nm in aqueous 
medium. This material did not show any significant 
cytotoxic effect with 10 to 50 μL/mL concentration on 
this HeLa cell line for at least up to 12 h of its 
treatment. The Mito-SiQDs could be useful a possible 
fluorescent marker to visualize mitochondrial 
subcellular compartment in living cell through 
fluorescence imaging study. 
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